Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2024 Earnings Call Transcript May 9, 2024Collegium Pharmaceutical, Inc. misses on earnings expectations.
Collegium Pharmaceutical Inc (COLL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 1,834,027 | $71,196,928 | -34% | 2.1% |
| 2. | 40,989,000 | $52,222,445 | 1.91% | ||
| 3. | 23,000,000 | $28,680,195 | 1.5% | ||
| 4. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 562,000 | $21,816,840 | 0.55% | |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 361,400 | $14,029,548 | +1% | 0.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.18 | 10,000 | Officer | 110,227 | 2017-05-12 | Filing | |
| $10.59 | 2,375 | Director | 2,375 | 2016-08-12 | Filing | |
| $12.00 | 3,930 | Large Shareholder | 65,270 | 2015-05-12 | Filing | |
| $12.00 | 196,070 | Large Shareholder | 3,256,572 | 2015-05-12 | Filing | |
| $12.00 | 150,000 | Large Shareholder, Director | 1,887,332 | 2015-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $32.30 | 28,985 | Director | 44,775 | 2024-05-14 | Filing | |
| $36.76 | 995 | Officer | 63,409 | 2024-02-29 | Filing | |
| $37.15 | 664 | Officer | 138,918 | 2024-02-26 | Filing | |
| $36.38 | 9,336 | Officer | 139,582 | 2024-02-26 | Filing | |
| $32.28 | 23,560 | Officer | 111,322 | 2024-01-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,786,993 | $178,123,645 | 0% | |
| 2. | 2,630,478 | $80,966,113 | 1.32% | |
| 3. | 2,312,786 | $71,187,552 | 0% | |
| 4. | 2,174,718 | $66,937,820 | 0.18% | |
| 5. | 1,569,151 | $48,298,467 | 0.03% |
News See All
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2023 Earnings Call Transcript
Collegium Pharmaceutical, Inc. misses on earnings expectations. Reported EPS is $0.82 EPS, expectations were $1.33.
13 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the 13 best short squeeze stocks to buy now.
Reasons to Invest in Collegium Pharmaceutical (COLL)
Third Avenue Management, an investment management company based in New York City, released its “Small-Cap Value Fund” fourth quarter 2023 investor letter.
12 Cheap NASDAQ Stocks To Buy
In this piece, we will take a look at the 12 cheap NASDAQ stocks to buy.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Collegium Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Collegium Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the five best small cap pharma stocks to buy.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Collegium Pharmaceutical First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
